TLCR Reading Tools
How to cite item
ALK-tyrosine kinase inhibitor resistance due to acquired
MET
amplification in
ALK
-fusion positive advanced NSCLC effectively treated by lorlatinib-vebreltinib combination: a case report and literature review
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{116521}, author = {Song, P., Liu, D., Liu, Y.}, title = {ALK-tyrosine kinase inhibitor resistance due to acquired <em>MET</em> amplification in <em>ALK</em>-fusion positive advanced NSCLC effectively treated by lorlatinib-vebreltinib combination: a case report and literature review}, journal = {Translational Lung Cancer Research}, volume = {15}, number = {4}, year = {2026}, url = {https://tlcr.amegroups.org/article/view/116521} }